Cytokine production in NK and NKT cells from Mycobacterium tuberculosis infected patients

Southeast Asian Journal of Tropical Medicine and Public Health

Volumn 38, Issue 2, 2007, Pages 370-375

  Kulpraneet, Manaphol ^a   Sukwit, Suchitra ^b   Sumransurp, Kwonchit ^a   Chuenchitra, Thippawan ^b   Santiwatanakul, Somchai ^a   Srisurapanon, Surangrat ^a  

^a SRINAKHARINWIROT UNIVERSITY   (Thailand)

^b ARMED FORCES RESEARCH INSTITUTE OF MEDICAL SCIENCES   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 34249699152     PISSN: 01251562     EISSN: 26975718     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Barnes PF, Abrams JS, Lu S, Sieling PA, Rea TH, Modlin RL. Patterns of cytokine production by mycobacterium-reactive human T-cell clones. Infect Immun 1993; 61: 197-203.
2. Bhattacharyya S, Singia R, Dey AB. Prasad HK. Dichotomy of cytokine profiles in patients and high-risk healthy subjects exposed to tuberculosis. Infect Immun 1999; 67: 5597-603.
3. Campos-Martin Y, Gomez del Moral M, Gozalbo-Lopez B, Suela J, Martinez-Naves E. Expression of human CD1d molecules protects target cells from NK cell-mediated cytolysis. J Immunol 2004; 172: 7297-305.
4. Carbone E, Terrazzano G, Melian A, et al. Inhibition of human NK cell-mediated killing by CD1 molecules. J Immunol 2000; 164: 6130-7.
5. Chackerlan A, Alt J, Perera V, Behar SM. Activation of NKT cells protects mice from tuberculosis. Infect Immun 2002; 70: 6302-9.
6. Dlugovitzky D, Bay M, Rateni L, et al. Influence of disease severity on nitrite and cytokine production by peripheral blood mononuclear cells (PBMC) from patients with pulmonary tuberculosis (TB). Clin Exp Immunol 2000; 122: 343-9.
7. Fischer K, Scotet E, Niemeyer M, et al. Mycobacterial phosphatidylinositol mannoside is a natural antigen for CD1d-restricted T cells. PNAS 2004; 101: 10685-90.
8. Flynn JL, Chan J, Triebold KJ, Dalton DK, Stewart TA, Bloom BR. An essential role for interferon gamma In resistance to Mycobacterium tuberculosis infection. J Exp Med 1993; 178: 2249-54.
9. Gansert JL, Kiebler V, Engele M, et al. Human NKT cells express granulysin and exhibit antimycobacterial activity. J Immunol 2003; 170: 3154-61.
10. Godfrey D, Hammond K, Poulton L, Smyth M, Baxter A. NKT cells: facts, functions and fallacies. Immunol Today 2000; 21: 573-83.
11. Godfrey DI, Kronenberg M. Going both ways: Immune regulation via CD1d-dependent NKT cells. J Clin Invest 2004; 114: 1379-88.
12. Jardim A, Alexander J, Teh H, Ou D, Olafson R. Immunoprotective Leishmania major synthetic T cell epitopes. J Exp Med 1990; 172: 645-8.
13. Junqueira-Kipnis AP, Kipnis A, Jamieson A, et al. NK cells respond to pulmonary infection with Mycobacterium tuberculosis, but play a minimal role In protection. J Immunol 2003; 171: 6039-45.
14. Liew F, Millott S, Schmidt J. A repetitive peptide of Leishmania can activate T helper type 2 cells and enhance disease progression. J Exp Med 1990; 172: 1359-65,
15. Moody DB, Guy MR, Grant E, et al. CD1b-mediated T cell recognition of a glycolipid antigen generated from mycobacterial lipid and host carbohydrate during infection. J Exp Med 2000; 192: 965-76.
16. Oki S, Chiba A, Yamamura T, Miyake S. The clinical implication and molecular mechanism of preferential IL-4 production by modified glycolipid-stimulated NKT cells. J Clin Invest 2004; 113: 1631-40.
17. Olsen I, Boysen P, Kulberg S, Hope JC, Jungersen G, Storset AK. Bovine NK cells can produce gamma interferon In response to the secreted mycobacterial proteins ESAT-6 and MPP14 but not in response to MPB70. Infect Immun 2005; 73: 5628-35.
18. Ortaldo JR, Young HA, Winkler-Pickett RT, Bere EW, Jr, Murphy WJ, Wiltrout RH. Dissociation of NKT stimulation, cytoklne induction, and NK activation in vivo by the use of distinct TCR-binding ceramides. J Immunol 2004; 172: 943-53.
19. Picker L, Singh M, Zdraveski Z, et al. Direct demonstration of cytokine synthesis heterogeneity among human memory/effector T cells by flow cytometry. Blood 1995; 86: 1408-19.
20. Saxena R, Weissman D, Saxena Q, Simpson J, Lewis D. Kinetics of changes in lymphocyte sub-populations in mouse lungs after intrapulmonary infection with M. bovis (Bacillus Calmette-Guerin) and identity of cells responsible for IFN-gamma responses. Clin Exp Immunol 2002; 128: 405-10.
21. Scharton T, Scott P. Natural killer cells are a source of interferon gamma that drives differentiation of CD4+ T cell subsets and induces early resistance to Leishmania major in mice. J Exp Med 1993; 178: 567-77.
22. Schmieg J, Yang G, Franck RW, Van Rooijen N, Tsuji M. Glycolipid presentation to natural killer T cells differs in an organ-dependent fashion. PAWS 2005; 102: 1127-32.
23. Ulrichs T, Moody DB, Grant E, Kaufmann SE, Porcelli SA. T-Cell responses to CD1-presented lipid antigens in humans with Mycobacterium tuberculosis infection. Infect Immun 2003; 71: 3076-87.
24. Vankayalapati R, Klucar P, Wizel B, et al. NK cells regulate CD8+ T cell effector function in response to an intracellular pathogen . J Immunol 2004; 172: 130-7.
25. WHO. The World Health Organization report 2004; changing history. Geneva: WHO, 2004.
26. Zeng ZH, Castano AR, Segelke BW, Stura EA, Peterson PA, Wilson IA. Crystal structure of mouse CD1: an MHC-like fold with a large hydrophobic binding groove. Science 1997; 277: 339-45.